The landscape of dementia diagnosis has progressed radically with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent tests that will detect Alzheimer's pathology yrs in advance of symptoms emerge. Even though these technological innovations represent impressive development in being familiar with neu